HEALTH

Eurecat provides knowledge and innovative technologies to work together with businesses in the health sector value chain

Contact

xavier catasus eurecat

Xavier Catasús

Head of Business Development | Health, Sport & Food Industries

Phone no. +34 637 816 439
xavi.catasus[at]eurecat.org

francesc massana eurecat

Francesc Massana

Business Development Manager | Health & Sports Industries

Phone no. +34 689 626 175
francesc.massana[at]eurecat.org

Juan Carrillo

Biotechnology Business Developer | Health, Sports & Food Industries

Phone no. +34 696 757 452
juan.carrillo[at]eurecat.org

In Health we work to develop new standout products, processes, services and solutions supporting businesses, hospitals and health institutions from the idea to its industrialisation.

Solutions for transforming health

1. Smart hospital of the future (Hospital 4.0)

  • Planning, optimising and reengineering healthcare processes
  • Control centre with digital twins, simulation tools and dashboard for smart hospital management
  • Liquid hospitals, home hospitalisation and hyper-specialisation of intra-hospitalservices
  • Healthcare robotics and artificial intelligence for automation and smart support
  • Health products, medical devices and PoC to enable and standardise diagnosis, intervention and monitoring

2. Integrated care and chronicity management

  • Self-management tools for patients and caregivers
  • Collaboration tools for healthcare and social professionals
  • Advanced services: patient empowerment, training, communication, follow-up, workflow management
  • Planning and monitoring the adaptive and flexible care plan
  • Virtual healthcare practice to reduce unnecessary trips and visits to optimise and prioritise added-value face-to-face visits
  • Improved adherence to treatments, not just pharmacological ones

3. Support systems for precision medicine

  • Data analytics in medicine: analysis and fusion of clinical, epidemiological picture, biological and environmental data
  • Application of statistical techniques, especially artificial intelligence and machine learning
  • Predictive and prescriptive models
  • Clinical decision support systems for screening, diagnosis, prognosis, therapy management and personalisation

4. Personalised medicine

  • Holistic and multilevel approach to the omic sciences: genomics, transcriptomics, proteomics, metabolomics
  • Understanding and interpreting the mechanisms of complex diseases from a deep biological perspective
  • Personalisation of medicine for each individual based on biology and interaction with the phenotype
  • Personalisation of pharmacological and non-pharmacological treatments, therapies and rehabilitation
  • Personalisation of biologically-based nutrition and interaction with lifestyle

5. Personalised medical devices

  • Design, development and functional validation of medical devices
  • Advanced and customised materials for implants, prostheses and orthotic devices
  • Automated generation of customised models of implants, prostheses and orthotic devices
  • Flexible and plastronic functional printing to implement medical devices with flexible electronics, sensors and nanomaterials
  • Smart and functional fabrics for health monitoring (wearables)
  • AI embedded in sensors and actuators for predictive medicine and PoC

6. Robotics to support physical and cognitive rehabilitation

  • Collaborativeand adaptive robotics
  • Robot behaviour engines
  • Recognising emotions and mood based on physiological signals
  • EEG, ECG, EDA, gesture and expression analysis
  • Digital therapeutics delivered through multimodal platforms including sensorised robots
  • Virtual and augmented reality for medical treatments and surround sound to apply audio-based therapies

7. Biosensors, lab-on-a-chip, organ-on-a-chip

  • Choice and validation of biomarkers in the design of biosensors and lab-on-a-chip , setup in the lab and translation on the device
  • Using omicsdata for organ-on-a-chip or lab-on-a-chip device characterisation , validation of suitability to test the biological effectiveness of active principles, ingredients or drugs
  • Microfluidics and flexible electronics technology to recreate organ activity and test new bioactive compounds
  • 3D bioprinting and biocompatibility

8. Personalised nutrition

  • Personalisation of biologically-based nutrition and interaction with lifestyle
  • AI approach to provide nutritional recommendations targeting people, functional microbiota. Traditional and emerging technologies to design, characterise and transform new ingredients meeting consumer preferences
  • Assessment of biological efficacy and description of the molecular mechanisms involved in the biological actions of foods, extracts, nutraceuticals, bioactive ingredients

Services

Biotech companies

  • Omics data generation (genomics, proteomics and metabolomics) and bioinformatics analysis of the data and machine learning in case of large data volumes

  • Stability, useful life and bioavailability studies for biotechnological molecules

  • Lab-on-a-chip and organ-on-a-chip technology development

  • In vitro, preclinical (in vivo) and clinical studies

  • Identification and characterisation of prebiotics, probiotics, postbiotics and paraprobiotics

  • Fermentation optimisation and scaling services

Medical technology companies

  • Medical devices development

  • Innovation in existing health products

  • Wearables to capture, measure and control biometric signals and parameters

  • Biomechanical analysis and rehabilitationdevices

  • AI-embedded smart patches

  • Flexible, plastronic, sensory electronics and touchless devices

  • Application of functional surface treatments (functional nanotexturing)

  • Application of microencapsulation for treatments in health products

  • Services and development for disinfection

  • Developing apps and platforms for patient-professional interaction

  • Data mining platforms

Pharmaceutical companies

  • Generation of omic data, bioinformatics analytics and processing large volumes of data

  • Microbiota studies (intestinal, dermal, environmental, etc.)

  • NMR-based interactomics studies

  • Epigenomics (DNA methylation, ChIP-Seq)

  • Guided proteomics for vaccine antigen characterisation

  • Intact protein proteomics and their post-translational modifications for characterising products of pharmacological interest

  • Studies of stability, useful life, bioavailability and pharmacokinetics of molecules

  • In vitro, preclinical (in vivo) and clinical studies

  • Identification and characterisation of prebiotics, probiotics, postbiotics and paraprobiotics

  • Preclinical studies targeting screening/high-throughput models, an alternative to small mammal ones (organ-on-a-chip for digestive health and zebrafish larvae)

  • Digestive health using advanced in vitro models (OOC) with microbiota modulating ingredients

  • Smart traceability projects (smart blisters)

  • Data analytics, machine learning and big data environment projects and studies for analysis and knowledge of consumers and the professional doctor channel or the distribution channel

  • Sustainability projects (energy efficiency, waste management, CO2 footprint, etc.)

  • Development of separation and purification processes

  • Treatment of recalcitrant compounds in wastewater

  • Biomanufacturing: bioprinters, 3D stents, organ-on-a-chip, scaffolds, melt electrospinning

  • IoT platforms and AI-based development (data and algorithmic)
  • Recommender platforms for prescriptive management (predictive maintenance, predictive quality, optimal autonomous control, resource optimisation)
  • Digital twins of industrial processes
  • Automatic parameterisation of equipment
  • Simulation and modelling of chemical processes
  • Advanced multiphysics simulation (mechanical, thermal, chemical, fluid dynamics)
  • Cybersecurity diagnostics (industrial) on IT/OT systems

Research centres

  • Omics procedures and analytics with bioinformatics analysis of the data obtained

  • Microbiota studies (intestinal, dermal, environmental, etc.)

  • NMR-based interactomics studies

  • Epigenomics (DNA methylation, ChIP-Seq)

  • Guided proteomics for vaccine antigen characterisation

  • Data analytics, machine learning and big data environment projects and studies

  • Preclinical and clinical studies

  • Preclinical studies targeting screening/high-throughput models, an alternative to small mammal ones (organ-on-a chip for digestive health and zebrafish larvae)

  • Smart traceability projects (smart blisters)

  • Biomanufacturing: bioprinters, 3D stents, organ-on-a-chip, scaffolds, melt electrospinning o )

Care providers

  • Omics data procedures and studies with bioinformatics analysis of the data and machine learning in case of large data volumes

  • Precision nutrition studies (personalised or group)

  • Applications and platforms for patients and professionals

  • Health promotion studies using digital tools

  • Point-of-care development for rapid diagnosis

  • Biomechanical analysis and rehabilitation devices

  • Wearables to measure and control biometric signals and parameters

  • Indoor positioning   of the asset and people

  • Consulting, managing and unlocking innovation

  • Health services through care and social robotics platforms

  • Hospital 4.0

Private clinics

  • Molecular studies for private clinics (genotyping, gene expression studies, microbiota analysis, metabolome analysis, metabotyping studies, etc.) with various biological fluids and tissues (urine, faeces, saliva, sweat, tears, cerebrospinal fluid, etc.)

  • Annual testing agreements with studies of large numbers of samples or more recurrent or regular samples

  • Skin health studies

  • Metabolic analyses in both faeces and plasma (fatty acids, bile acids, lipidomics, amino acids, acylcarnitines, etc.)

  • Functional microbiota studies including metagenomics and metaproteomics studies

  • Studies of post-translational modifications (PTMs)

  • Development of digital platforms for professionals

  • Health promotion and follow-up studies using digital tools

Ministry of Health (government)

  • Public health analysis tools

  • Analysis of the impact of epidemics

  • Analysis of the impact of the environment

  • Analysis of the impact of climate change on health

Cross-cutting services

  • Technology watch, sector trends “radar” and competitive intelligence
  • Innovation strategy: Lean management, Industry 4.0 Roadmaps, Circular Economy Roadmap
  • Intellectual/industrial property studies
  • Technological due diligence
  • Specialised training: Industry 4.0, cybersecurity, artificial intelligence, circular economy, robotics
  • Entrepreneurship training programmes
  • Conceptualisation and proofs-of-concept
  • Prototyping
  • Short runs and field validation
  • Support for industrialising
  • Certification support
  • Smart platforms for controlling sensors and data
  • Data architecture: information system cross-correlation and analytics for decision making
  • Determination of complex parameters using virtual sensors (soft sensing)
  • Integration and communication of information with management systems
  • Secure information exchange using digital smart contracts and blockchain
  • Solutions for the digital security of equipment and facilities
  • Solutions for the digital security of medical devices
  • Control system for cyber-physical threats in critical infrastructures

OCA-WAS, the Eurecat control body accredited according to the UNE-EN ISO/IEC 17020 standard in the field of major accidents

Eurecat offers companies the OCA-WAS control body with the aim of supporting the professional activity of companies through the evaluation of safety reports (SI) and Quantitative Risk Analysis reports (QRA).

We have the necessary technical means to prevent accidents involving hazardous substances, thus limiting their consequences on human health and the environment.

Facilities

Biotechnology and Omic Sciences Laboratory

Nutrition and Food Technologies

Smart Objects Laboratory

Plastronics Pilot Plant

Industrial Laboratory

Outstanding projects

DIPNEO

Autonomous medical device for cardiorespiratory arrests

Dipneo is to develop and market a new medical device for resuscitation in case of cardiorespiratory arrest. It is based on a new system patented by Eurecat which allows air to be blown into the patient autonomously.

Evisió

Ophthalmology Territorial Innovation Project for decentralising care, online vision self-testing and user empowerment

The main goal is to improve the eye health of people in l’Alt Empordà by making it easier for patients to get ophthalmological care and reducing referrals

NHOA

Never Home Alone

Social assistance robotic system to prevent loneliness and isolation by helping the elderly to live independently at home.

Sarsaigua

Setting up the wastewater analytical surveillance platform

The goal is to monitor genetic traces of the SARS-COV-2 virus in Catalan wastewater treatment plants to control its concentration in towns and thus implement preventive measures to curb its spread.

Success stories

Sector news